News
Drug and biotech news
Last checked: Nov 20, 2026Source: BioPharma Dive, STAT (pharma), FDA press releases, FDA MedWatch, Drugs@FDA (new approvals), openFDA (Class I recalls)
4 stories
Tagged Oncology from the headline and teaser, so some stories may be missed or misfiled.
- FDA approvalDrugs@FDANov 10, 2026FDA novel drug approval: Pimjetmi (Pimicotinib), Emd Serono
To treat adults with symptomatic tenosynovial giant cell tumors in whom surgical resection may cause worsening functional limitation or severe morbidity
- FDA approvalDrugs@FDAOct 19, 2026FDA new use approved: Jemperli (Dostarlimab-Gxly), Glaxosmithkline
Efficacy supplement 15. Priority review.
- FDA approvalDrugs@FDAOct 16, 2026FDA new use approved: Ayvakit (Avapritinib), Blueprint Medicines
Efficacy supplement 21. Orphan.
- FDA approvalDrugs@FDAOct 7, 2026FDA new use approved: Tukysa (Tucatinib), Seagen
Efficacy supplement 10. Orphan.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.